LCTX vs BIIB: Which Stock is Better?
Side-by-side comparison of Lineage Cell Therapeutics Inc and Biogen Inc in 2026
LCTX
Lineage Cell Therapeutics Inc
$1.71
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | LCTX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $425.94M | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | 1.3% | -0.1% | LCTX |
| Gross Margin | -22.8% | 78.9% | BIIB |
Analyze LCTX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is LCTX or BIIB a better investment?
Comparing LCTX and BIIB: Lineage Cell Therapeutics Inc has a market cap of $425.94M while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between LCTX and BIIB?
LCTX (Lineage Cell Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: LCTX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: LCTX or BIIB?
LCTX has higher revenue growth at 1.3% vs -0.1% for BIIB.
Which company is more profitable: LCTX or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -22.8% for LCTX.
Which is the larger company: LCTX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $425.94M for LCTX.
Should I buy LCTX or BIIB in 2026?
Both LCTX and BIIB have investment merit. LCTX trades at $1.71 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between LCTX and BIIB stock?
Key differences: Market Cap ($425.94M vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (1.3% vs -0.1%), Gross Margin (-22.8% vs 78.9%).